Hesketh, Paul
first name: Paul
last name: Hesketh
coauthor of: Lamb, Carla
coauthor of: Wald, Christoph
coauthor of: Piper-Vallillo, Andrew
coauthor of: Mosenthal, Anne
coauthor of: Flacke, Sebastian
full name: Paul Joseph Hesketh MD
has faculty rank: Professor
has network: research areas
has network: coauthor of
has network: similar to
has network: selected publications
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247887
person in primary position: Professor
physical neighbor: Fraga, Polly
physical neighbor: Green, Eric
physical neighbor: Hasan, Imran
physical neighbor: Lo, Elizabeth
physical neighbor: Orfanos, Gerry
similar to: Usmani, Saad
similar to: Weiss, Glen
similar to: Martinez, Fernando
similar to: Shin, Dong-Soo
similar to: Xiao, Hang
type: Agent
type: Person
selected publications: Authorship 132684
selected publications: Authorship 121331
selected publications: Authorship 121347
selected publications: Authorship 121316
selected publications: Authorship 121315
selected publications: Authorship 121329
selected publications: Authorship 121251
selected publications: Authorship 121283
selected publications: Authorship 121227
selected publications: Authorship 121272
selected publications: Authorship 121240
selected publications: Authorship 121217
selected publications: Authorship 121202
selected publications: Authorship 121443
selected publications: Authorship 121162
selected publications: Authorship 121163
selected publications: Authorship 121435
selected publications: Authorship 121434
selected publications: Authorship 121139
selected publications: Authorship 121153
selected publications: Authorship 121150
selected publications: Authorship 121132
selected publications: Authorship 121138
selected publications: Authorship 121140
selected publications: Authorship 121130
selected publications: Authorship 121191
selected publications: Authorship 121189
selected publications: Authorship 121187
selected publications: Authorship 121218
selected publications: Authorship 121128
selected publications: Authorship 121185
selected publications: Authorship 121154
selected publications: Authorship 121198
selected publications: Authorship 121442
selected publications: Authorship 121437
selected publications: Authorship 121439
selected publications: Authorship 121182
selected publications: Authorship 121173
selected publications: Authorship 121135
selected publications: Authorship 121447
selected publications: Authorship 121418
selected publications: Authorship 121412
selected publications: Authorship 121428
selected publications: Authorship 121422
selected publications: Authorship 121387
selected publications: Authorship 121425
selected publications: Authorship 121426
selected publications: Authorship 121433
selected publications: Authorship 121424
selected publications: Authorship 121423

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

educational organization
tag name: prns:trainingAtOrganization
type: DatatypeProperty

training location
tag name: prns:trainingLocation
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Endowed Chair Honorary Title
tag name: umass:honoraryTitle
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

degree earned
tag name: vivo:degreeEarned
type: ObjectProperty

Department
type: Class

Division
type: Class

education and training
tag name: vivo:educationalTraining
type: Class
type: ObjectProperty
label: Educational Training

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

major field of degree
tag name: vivo:majorField
type: DatatypeProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Antineoplastic Combined Chemotherapy Protocols
MeSH DescriptorUI: D000971
MeSH semantic group name: Procedures
number of authors: 136
number of publications: 449
uniqueness weight: 0.750717
type: Concept

Nausea
MeSH DescriptorUI: D009325
MeSH semantic group name: Disorders
number of authors: 32
number of publications: 111
uniqueness weight: 0.926866
type: Concept

Antineoplastic Agents
MeSH DescriptorUI: D000970
MeSH semantic group name: Chemicals & Drugs
number of authors: 249
number of publications: 663
uniqueness weight: 0.668949
type: Concept

Vomiting
MeSH DescriptorUI: D014839
MeSH semantic group name: Disorders
number of authors: 40
number of publications: 137
uniqueness weight: 0.90875
type: Concept

Antiemetics
MeSH DescriptorUI: D000932
MeSH semantic group name: Chemicals & Drugs
MeSH semantic group name: Physiology
number of authors: 16
number of publications: 95
uniqueness weight: 0.919846
type: Concept

Medicine
type: Department
type: Organization

College of Natural Sciences
type: Department
type: Organization

Food Science
type: Division
type: Organization

Health Informatics And Implementation Science
type: Division
type: Organization

T.H. Chan School of Medicine
type: Organization

UMass Chan Medical School
type: Organization

University of Massachusetts Amherst
type: Organization

Xiao, Hang
first name: Hang
last name: Xiao
full name: Hang Xiao PhD
has faculty rank: Associate Professor
latitude: 42.39565560000000
longitude: -72.52196170000000
Person ID: 3795
person in primary position: Associate Professor
type: Agent
type: Person
preferred title: Associate Professor

UMass Chan – Baystate Regional Campus
type: Organization

Associate Professor
is primary position: true
position in department: College of Natural Sciences
position in division: Food Science
sort order: 1
type: Position
HR job title: Associate Professor
position in organization: University of Massachusetts Amherst

Boston College, Biology
educational organization: Boston College
training location: Chestnut Hill, MA, United States
type: EducationalTraining
degree earned: BS
major field of degree: Biology

University of Connecticut School of Medicine,
educational organization: University of Connecticut School of Medicine
training location: Farmington, CT, United States
type: EducationalTraining
degree earned: MD

ADJUNCT PROFESSOR
sort order: 46
type: Faculty Rank

Usmani, Saad
first name: Saad
last name: Usmani
full name: Saad Usmani MD
has faculty rank: Instructor
latitude: 42.07492460000000
longitude: -72.52221600000000
Person ID: 5394
person in primary position: Instructor
type: Agent
type: Person
preferred title: Instructor

Population and Quantitative Health Sciences
type: Department
type: Organization

Development of a Novel Communication Liaison Program to Support COVID-19 Patients and Their Families.
PubMed Identifier: 33246074
author list: Lipworth AD, Collins EJ, Keitz SA, Hesketh PJ, Resnic FS, Wozniak JM, Mosenthal AC
published in: Journal of pain and symptom management
information resource reference: Lipworth AD, Collins EJ, Keitz SA, Hesketh PJ, Resnic FS, Wozniak JM, Mosenthal AC. Development of a Novel Communication Liaison Program to Support COVID-19 Patients and Their Families. J Pain Symptom Manage. 2021 01; 61(1):e1-e10.
journal title abbreviation: J Pain Symptom Manage
publication date: 2020-11-24T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Medicine at UMass Chan - Baystate
type: Department
type: Organization

Instructor
is primary position: true
position in department: Medicine at UMass Chan - Baystate
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Instructor
position in organization: UMass Chan – Baystate Regional Campus

Weiss, Glen
first name: Glen
last name: Weiss
full name: Glen Weiss MD, MBA
has faculty rank: Associate Professor
latitude: 42.27525000000000
longitude: -71.76233800000000
photo: https://profiles.umassmed.edu/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 10247163
person in primary position: Associate Professor
type: Agent
type: Person
preferred title: Associate Professor

Lo, Elizabeth
first name: Elizabeth
last name: Lo
full name: Elizabeth P Lo MD
has faculty rank: Assistant Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247647
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Mosenthal, Anne
first name: Anne
last name: Mosenthal
full name: Anne C Mosenthal MD, FACS, MAMSE
has faculty rank: Professor
latitude: 42.48526100000000
longitude: -71.20221980000000
Person ID: 10247657
person in primary position: Professor
type: Agent
type: Person
preferred title: Professor

Medicine at UMass Chan - Lahey
type: Department
type: Organization

Surgery at UMass Chan - Lahey
type: Department
type: Organization

Professor
is primary position: true
position in department: Surgery at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Radiology at UMass Chan - Lahey
type: Department
type: Organization

Hasan, Imran
first name: Imran
last name: Hasan
full name: Imran S Hasan MD, MS
has faculty rank: Assistant Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247711
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Fraga, Polly
first name: Polly
last name: Fraga
full name: Polly D Fraga MD
has faculty rank: Associate Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247712
person in primary position: Associate Professor
type: Agent
type: Person
preferred title: Associate Professor

Orfanos, Gerry
first name: Gerry
last name: Orfanos
full name: Gerry Orfanos MD
has faculty rank: Assistant Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247718
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Wald, Christoph
first name: Christoph
last name: Wald
full name: Christoph Wald MD, PhD, MBA, FACR
has faculty rank: Chair And Professor
latitude: 42.48526100000000
longitude: -71.20221980000000
Person ID: 10247725
person in primary position: Chair and Professor
type: Agent
type: Person
preferred title: Chair and Professor

Surgical Outcomes in a Large, Clinical, Low-Dose Computed Tomographic Lung Cancer Screening Program.
PubMed Identifier: 26209493
author list: Walker BL, Williamson C, Regis SM, McKee AB, D'Agostino RS, Hesketh PJ, Lamb CR, Flacke S, Wald C, McKee BJ
published in: The Annals of thoracic surgery
information resource reference: Walker BL, Williamson C, Regis SM, McKee AB, D'Agostino RS, Hesketh PJ, Lamb CR, Flacke S, Wald C, McKee BJ. Surgical Outcomes in a Large, Clinical, Low-Dose Computed Tomographic Lung Cancer Screening Program. Ann Thorac Surg. 2015 Oct; 100(4):1218-23.
journal title abbreviation: Ann Thorac Surg
publication date: 2015-07-22T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer.
PubMed Identifier: 26846536
author list: McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, Williamson C, Flacke S, Wald C
published in: Journal of the American College of Radiology : JACR
information resource reference: McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, Williamson C, Flacke S, Wald C. Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer. J Am Coll Radiol. 2016 Feb; 13(2 Suppl):R8-R13.
journal title abbreviation: J Am Coll Radiol
publication date: 2016-02-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Initial experience with a free, high-volume, low-dose CT lung cancer screening program.
PubMed Identifier: 23623708
author list: McKee BJ, McKee AB, Flacke S, Lamb CR, Hesketh PJ, Wald C
published in: Journal of the American College of Radiology : JACR
information resource reference: McKee BJ, McKee AB, Flacke S, Lamb CR, Hesketh PJ, Wald C. Initial experience with a free, high-volume, low-dose CT lung cancer screening program. J Am Coll Radiol. 2013 Aug; 10(8):586-92.
journal title abbreviation: J Am Coll Radiol
publication date: 2013-04-26T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Experience with a CT screening program for individuals at high risk for developing lung cancer.
PubMed Identifier: 25176498
author list: McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, Williamson C, Flacke S, Wald C
published in: Journal of the American College of Radiology : JACR
information resource reference: McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, Williamson C, Flacke S, Wald C. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol. 2015 Feb; 12(2):192-7.
journal title abbreviation: J Am Coll Radiol
publication date: 2014-08-28T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Health System Science
type: Division
type: Organization

Pulmonary Medicine
type: Division
type: Organization

Flacke, Sebastian
first name: Sebastian
last name: Flacke
full name: Sebastian Flacke MD, PhD
has faculty rank: Professor
latitude: 42.48526100000000
longitude: -71.20221980000000
Person ID: 10247763
person in primary position: Professor
type: Agent
type: Person
preferred title: Professor

Professor
is primary position: true
position in department: Radiology at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

Burlington MA 01803
type: Address
address line 1: Lahey Hospital and Medical Center
address line 2: 67 South Bedford Street
address line 3: Burlington MA 01803

Green, Eric
first name: Eric
last name: Green
full name: Eric H Green MD, MSc, FACP
has faculty rank: Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247886
person in primary position: Professor
type: Agent
type: Person
preferred title: Professor

research areas
maximum weight: 13.6658
minimum weight: 0.00464159
number of connections: 314
predicate node: https://profiles.umassmed.edu/profile/198
predicate: research areas
type: Network

coauthor of
maximum weight: 0.541243
minimum weight: 0.00838794
number of connections: 7
predicate node: https://profiles.umassmed.edu/profile/345
predicate: coauthor of
type: Network

similar to
maximum weight: 192.472
minimum weight: 12.4641
number of connections: 60
predicate node: https://profiles.umassmed.edu/profile/476
predicate: similar to
type: Network

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 155
predicate node: https://profiles.umassmed.edu/profile/94
predicate: selected publications
type: Network

Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

https://profiles.umassmed.edu/profile/46818172
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 2
type: Position
position in organization: T.H. Chan School of Medicine

Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

Authorship 121128
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.

Authorship 121130
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Authorship 121132
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Authorship 121135
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Experience with a CT screening program for individuals at high risk for developing lung cancer.

Authorship 121138
type: Authorship
author rank in publication: 10
linked author: Hesketh, Paul
linked information resource: Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.

Authorship 121139
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Authorship 121140
type: Authorship
author rank in publication: 11
linked author: Hesketh, Paul
linked information resource: 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

Authorship 121143
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.

Authorship 121146
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.

Authorship 121147
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.

Authorship 121150
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authorship 121151
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma.

Authorship 121153
type: Authorship
author rank in publication: 8
linked author: Hesketh, Paul
linked information resource: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authorship 121154
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Authorship 121155
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Oral ondansetron: a useful addition to the supportive care armamentarium?

Authorship 121156
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Control of chemotherapy-induced emesis.

Authorship 121157
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.

Authorship 121158
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Serotonin antagonists in the management of cisplatin-induced emesis.

Authorship 121159
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Role of adjuvant therapy in colorectal cancer.

Authorship 121160
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Prognostic assessment in nonseminomatous testicular cancer: implications for therapy.

Authorship 121162
type: Authorship
author rank in publication: 12
linked author: Hesketh, Paul
linked information resource: Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.

Authorship 121163
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic.

Authorship 121164
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.

Authorship 121165
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Evaluation and treatment of testicular cancer.

Authorship 121166
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.

Authorship 121167
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: The increasing frequency of adenocarcinoma of the esophagus.

Authorship 121169
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide.

Authorship 121170
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Management of cisplatin-induced delayed emesis.

Authorship 121171
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848198

Authorship 121173
type: Authorship
author rank in publication: 6
linked author: Hesketh, Paul
linked information resource: Surgical Outcomes in a Large, Clinical, Low-Dose Computed Tomographic Lung Cancer Screening Program.

Authorship 121174
type: Authorship
author rank in publication: 7
linked author: Hesketh, Paul
linked information resource: Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.

Authorship 121175
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.

Authorship 121177
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authorship 121179
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.

Authorship 121182
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting.

Authorship 121183
type: Authorship
author rank in publication: 10
linked author: Hesketh, Paul
linked information resource: Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.

Authorship 121185
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer.

Authorship 121187
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Reply to J. Jupp et al.

Authorship 121189
type: Authorship
author rank in publication: 6
linked author: Hesketh, Paul
linked information resource: 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.

Authorship 121191
type: Authorship
author rank in publication: 7
linked author: Hesketh, Paul
linked information resource: 2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents.

Authorship 121194
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.

Authorship 121195
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848041

Authorship 121196
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.

Authorship 121198
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848104

Authorship 121199
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.

Authorship 121200
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.

Authorship 121202
type: Authorship
author rank in publication: 9
linked author: Hesketh, Paul
linked information resource: Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.

Authorship 121204
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848164

Authorship 121207
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Adrenal hemorrhage secondary to metastasis from lung cancer.

Authorship 121208
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Uncommon hematologic malignancies. Case 2. Calcification in untreated primary mediastinal large B-cell lymphoma with sclerosis.

Authorship 121209
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.

Authorship 121213
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.

Authorship 121217
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetics: ASCO Guideline Update.

Authorship 121218
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.

Authorship 121226
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.

Authorship 121227
type: Authorship
author rank in publication: 9
linked author: Hesketh, Paul
linked information resource: Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.

Authorship 121240
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Cannabinoids as antiemetics: everything that's old is new again.

Authorship 121251
type: Authorship
author rank in publication: 11
linked author: Hesketh, Paul
linked information resource: Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.

Authorship 121257
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.

Authorship 121258
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.

Authorship 121261
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Acute emesis: moderately emetogenic chemotherapy.

Authorship 121262
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.

Authorship 121263
type: Authorship
author rank in publication: 7
linked author: Hesketh, Paul
linked information resource: Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.

Authorship 121265
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

Authorship 121272
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Development of a Novel Communication Liaison Program to Support COVID-19 Patients and Their Families.

Authorship 121273
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.

Authorship 121275
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.

Authorship 121282
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.

Authorship 121283
type: Authorship
author rank in publication: 11
linked author: Hesketh, Paul
linked information resource: Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.

Authorship 121287
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.

Authorship 121290
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.

Authorship 121291
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.

Authorship 121292
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?

Authorship 121295
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848201

Authorship 121299
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results.

Authorship 121304
type: Authorship
author rank in publication: 8
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848086

Authorship 121308
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.

Authorship 121310
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

Authorship 121312
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Chemotherapy-induced nausea and vomiting.

Authorship 121314
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Authorship 121315
type: Authorship
author rank in publication: 6
linked author: Hesketh, Paul
linked information resource: 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.

Authorship 121316
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Authorship 121324
type: Authorship
author rank in publication: 8
linked author: Hesketh, Paul
linked information resource: The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.

Authorship 121325
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46847914

Authorship 121329
type: Authorship
author rank in publication: 9
linked author: Hesketh, Paul
linked information resource: Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.

Authorship 121331
type: Authorship
author rank in publication: 9
linked author: Hesketh, Paul
linked information resource: 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.

Authorship 121343
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.

Authorship 121347
type: Authorship
author rank in publication: 8
linked author: Hesketh, Paul
linked information resource: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation.

Authorship 121348
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Serotonin antagonists: a new class of antiemetic agents.

Authorship 121349
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).

Authorship 121353
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.

Authorship 121358
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.

Authorship 121359
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.

Authorship 121360
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Lung cancer in octogenarians.

Authorship 121361
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.

Authorship 121362
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC).

Authorship 121363
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Cisplatin-based treatment of adrenocortical carcinoma.

Authorship 121364
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Palliative care in the cancer patient.

Authorship 121367
type: Authorship
author rank in publication: 12
linked author: Hesketh, Paul
linked information resource: Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Authorship 121369
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C.

Authorship 121370
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.

Authorship 121371
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Birth and re-birth.

Authorship 121372
type: Authorship
author rank in publication: 7
linked author: Hesketh, Paul
linked information resource: Acute emesis: moderately emetogenic chemotherapy.

Authorship 121373
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo.

Authorship 121375
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.

Authorship 121376
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Breast cancer in elderly women: presentation, survival, and treatment options.

Authorship 121377
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Drug treatment of chemotherapy-induced delayed emesis.

Authorship 121378
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848123

Authorship 121379
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.

Authorship 121380
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.

Authorship 121381
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy.

Authorship 121383
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials.

Authorship 121384
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

Authorship 121385
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Proposal for classifying the acute emetogenicity of cancer chemotherapy.

Authorship 121386
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.

Authorship 121387
type: Authorship
author rank in publication: 6
linked author: Hesketh, Paul
linked information resource: Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.

Authorship 121388
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.

Authorship 121389
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.

Authorship 121390
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence.

Authorship 121391
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.

Authorship 121393
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Paclitaxel and concurrent radiation for gastric cancer.

Authorship 121394
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting.

Authorship 121395
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.

Authorship 121397
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.

Authorship 121398
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Authorship 121399
type: Authorship
author rank in publication: 11
linked author: Hesketh, Paul
linked information resource: Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in Cancer.

Authorship 121401
type: Authorship
author rank in publication: 6
linked author: Hesketh, Paul
linked information resource: Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin.

Authorship 121404
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

Authorship 121406
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.

Authorship 121407
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: New treatment options for chemotherapy-induced nausea and vomiting.

Authorship 121409
type: Authorship
author rank in publication: 12
linked author: Hesketh, Paul
linked information resource: Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.

Authorship 121412
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Initial experience with a free, high-volume, low-dose CT lung cancer screening program.

Authorship 121413
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Penny wise, dollar foolish approach to antiemetic use may compromise patient care.

Authorship 121414
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium.

Authorship 121415
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.

Authorship 121416
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848197

Authorship 121417
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization.

Authorship 121418
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Lung cancer screening.

Authorship 121422
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO.

Authorship 121423
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848103

Authorship 121424
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Authorship 121425
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy.

Authorship 121426
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting.

Authorship 121428
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC).

Authorship 121433
type: Authorship
author rank in publication: 2
linked author: Hesketh, Paul
linked information resource: Antiemetics: american society of clinical oncology clinical practice guideline update.

Authorship 121434
type: Authorship
author rank in publication: 12
linked author: Hesketh, Paul
linked information resource: Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Authorship 121435
type: Authorship
author rank in publication: 9
linked author: Hesketh, Paul
linked information resource: Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.

Authorship 121437
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.

Authorship 121439
type: Authorship
author rank in publication: 3
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46847968

Authorship 121442
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Antiemetics: American Society of Clinical Oncology Focused Guideline Update.

Authorship 121443
type: Authorship
author rank in publication: 12
linked author: Hesketh, Paul
linked information resource: Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.

Authorship 121447
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: https://profiles.umassmed.edu/profile/46848188

Adrenal hemorrhage secondary to metastasis from lung cancer.
PubMed Identifier: 14706168
author list: Oo TH, Martin L, Hesketh PJ
published in: Clinical lung cancer
information resource reference: Oo TH, Martin L, Hesketh PJ. Adrenal hemorrhage secondary to metastasis from lung cancer. Clin Lung Cancer. 2002 Nov; 4(3):183-5.
journal title abbreviation: Clin Lung Cancer
publication date: 2002-11-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.
PubMed Identifier: 14653876
author list: Hesketh PJ, Nauman CJ, Hesketh AM, LaPointe J, Fogarty K, Oo TH, Lau DH, Edelman MJ, Gandara DR
published in: Clinical lung cancer
information resource reference: Hesketh PJ, Nauman CJ, Hesketh AM, LaPointe J, Fogarty K, Oo TH, Lau DH, Edelman MJ, Gandara DR. Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer. Clin Lung Cancer. 2002 Jul; 4(1):47-51.
journal title abbreviation: Clin Lung Cancer
publication date: 2002-07-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy-induced nausea and vomiting.
PubMed Identifier: 18525044
author list: Hesketh PJ
published in: The New England journal of medicine
information resource reference: Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008 Jun 05; 358(23):2482-94.
journal title abbreviation: N Engl J Med
publication date: 2008-06-05T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
PubMed Identifier: 14770445
author list: Hesketh PJ, Arena F, Patel D, Austin M, D'Avirro P, Rossi G, Colowick A, Schwartzberg L, Bertoli LF, Cole JT, Demetri G, Dessypris E, Dobbs T, Eisenberg P, Fleischman R, Hall J, Hoffman PC, Laber DA, Leonard J, Lester EP, McCachren S, McMeekin S, Meza L, Miller DS, Nand S, Oliff I, Paroly W, Pawl L, Perez A, Raftopoulos H, Rigas J, Rowland K, Scullin DC, Tezcan H, Waples J, Ward J, Yee LK
published in: Cancer
information resource reference: Hesketh PJ, Arena F, Patel D, Austin M, D'Avirro P, Rossi G, Colowick A, Schwartzberg L, Bertoli LF, Cole JT, Demetri G, Dessypris E, Dobbs T, Eisenberg P, Fleischman R, Hall J, Hoffman PC, Laber DA, Leonard J, Lester EP, McCachren S, McMeekin S, Meza L, Miller DS, Nand S, Oliff I, Paroly W, Pawl L, Perez A, Raftopoulos H, Rigas J, Rowland K, Scullin DC, Tezcan H, Waples J, Ward J, Yee LK. A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies. Cancer. 2004 Feb 15; 100(4):859-68.
journal title abbreviation: Cancer
publication date: 2004-02-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC).
PubMed Identifier: 22733373
author list: Hesketh PJ, Morrow G, Komorowski AW, Ahmed R, Cox D
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Morrow G, Komorowski AW, Ahmed R, Cox D. Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC). Support Care Cancer. 2012 Oct; 20(10):2633-7.
journal title abbreviation: Support Care Cancer
publication date: 2012-06-24T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
PubMed Identifier: 38458657
author list: Herrstedt J, Clark-Snow R, Ruhlmann CH, Molassiotis A, Olver I, Rapoport BL, Aapro M, Dennis K, Hesketh PJ, Navari RM, Schwartzberg L, Affronti ML, Garcia-Del-Barrio MA, Chan A, Celio L, Chow R, Fleury M, Gralla RJ, Giusti R, Jahn F, Iihara H, Maranzano E, Radhakrishnan V, Saito M, Sayegh P, Bosnjak S, Zhang L, Lee J, Ostwal V, Smit T, Zilic A, Jordan K, Scott? F
published in: ESMO open
information resource reference: Herrstedt J, Clark-Snow R, Ruhlmann CH, Molassiotis A, Olver I, Rapoport BL, Aapro M, Dennis K, Hesketh PJ, Navari RM, Schwartzberg L, Affronti ML, Garcia-Del-Barrio MA, Chan A, Celio L, Chow R, Fleury M, Gralla RJ, Giusti R, Jahn F, Iihara H, Maranzano E, Radhakrishnan V, Saito M, Sayegh P, Bosnjak S, Zhang L, Lee J, Ostwal V, Smit T, Zilic A, Jordan K, Scott? F. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open. 2024 Feb; 9(2):102195.
journal title abbreviation: ESMO Open
publication date: 2024-01-11T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46847914
PubMed Identifier: 1453211
author list: Beck TM, Hesketh PJ, Madajewicz S, Navari RM, Pendergrass K, Lester EP, Kish JA, Murphy WK, Hainsworth JD, Gandara DR
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Beck TM, Hesketh PJ, Madajewicz S, Navari RM, Pendergrass K, Lester EP, Kish JA, Murphy WK, Hainsworth JD, Gandara DR, et al. Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol. 1992 Dec; 10(12):1969-75.
journal title abbreviation: J Clin Oncol
publication date: 1992-12-01T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting.

Prognostic assessment in nonseminomatous testicular cancer: implications for therapy.
PubMed Identifier: 2162974
author list: Hesketh PJ, Krane RJ
published in: The Journal of urology
information resource reference: Hesketh PJ, Krane RJ. Prognostic assessment in nonseminomatous testicular cancer: implications for therapy. J Urol. 1990 Jul; 144(1):1-9.
journal title abbreviation: J Urol
publication date: 1990-07-01T00:00:00
year: 1990
type: Academic Article
type: Article
type: Document
type: Information Resource

Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
PubMed Identifier: 18758306
author list: Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Hesketh PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley JJ, Gandara DR. Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2. J Thorac Oncol. 2008 Sep; 3(9):1026-31.
journal title abbreviation: J Thorac Oncol
publication date: 2008-09-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Acute emesis: moderately emetogenic chemotherapy.
PubMed Identifier: 20680356
author list: Herrstedt J, Rapoport B, Warr D, Roila F, Bria E, Rittenberg C, Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Herrstedt J, Rapoport B, Warr D, Roila F, Bria E, Rittenberg C, Hesketh PJ. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer. 2011 Mar; 19 Suppl 1:S15-23.
journal title abbreviation: Support Care Cancer
publication date: 2010-08-02T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Cisplatin-based treatment of adrenocortical carcinoma.
PubMed Identifier: 2433038
author list: Hesketh PJ, McCaffrey RP, Finkel HE, Larmon SS, Griffing GT, Melby JC
published in: Cancer treatment reports
information resource reference: Hesketh PJ, McCaffrey RP, Finkel HE, Larmon SS, Griffing GT, Melby JC. Cisplatin-based treatment of adrenocortical carcinoma. Cancer Treat Rep. 1987 Feb; 71(2):222-4.
journal title abbreviation: Cancer Treat Rep
publication date: 1987-02-01T00:00:00
year: 1987
type: Academic Article
type: Article
type: Document
type: Information Resource

Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium.
PubMed Identifier: 20956915
author list: Morrow GR, Hesketh PJ, Schwartzberg LS, Ettinger DS
published in: Clinical advances in hematology & oncology : H&O
information resource reference: Morrow GR, Hesketh PJ, Schwartzberg LS, Ettinger DS. Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium. Clin Adv Hematol Oncol. 2010 May; 8(5 Suppl 9):1-16.
journal title abbreviation: Clin Adv Hematol Oncol
publication date: 2010-05-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Palliative care in the cancer patient.
PubMed Identifier: 2442236
author list: Hesketh PJ
published in: Journal of the American Geriatrics Society
information resource reference: Hesketh PJ. Palliative care in the cancer patient. J Am Geriatr Soc. 1987 Sep; 35(9):883-5.
journal title abbreviation: J Am Geriatr Soc
publication date: 1987-09-01T00:00:00
year: 1987
type: Academic Article
type: Article
type: Document
type: Information Resource

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.
PubMed Identifier: 20803039
author list: Kris MG, Tonato M, Bria E, Ballatori E, Espersen B, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Saito M, Morrow G, Hesketh P
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Kris MG, Tonato M, Bria E, Ballatori E, Espersen B, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Saito M, Morrow G, Hesketh P. Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer. 2011 Mar; 19 Suppl 1:S25-32.
journal title abbreviation: Support Care Cancer
publication date: 2010-08-28T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation and treatment of testicular cancer.
PubMed Identifier: 2484998
author list: Hesketh PJ
published in: Hospital practice (Office ed.)
information resource reference: Hesketh PJ. Evaluation and treatment of testicular cancer. Hosp Pract (Off Ed). 1987 Sep 30; 22(9A):87-90, 93-102.
journal title abbreviation: Hosp Pract (Off Ed)
publication date: 1987-09-30T00:00:00
year: 1987
type: Academic Article
type: Article
type: Document
type: Information Resource

Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
PubMed Identifier: 16264934
author list: Oo TH, Hesketh PJ
published in: Nature clinical practice. Oncology
information resource reference: Oo TH, Hesketh PJ. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting. Nat Clin Pract Oncol. 2005 Apr; 2(4):196-201.
journal title abbreviation: Nat Clin Pract Oncol
publication date: 2005-04-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.
PubMed Identifier: 15221580
author list: Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D. Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer. 2004 Aug; 12(8):543-9.
journal title abbreviation: Support Care Cancer
publication date: 2004-06-19T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

New treatment options for chemotherapy-induced nausea and vomiting.
PubMed Identifier: 15232725
author list: Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ. New treatment options for chemotherapy-induced nausea and vomiting. Support Care Cancer. 2004 Aug; 12(8):550-4.
journal title abbreviation: Support Care Cancer
publication date: 2004-06-30T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.
PubMed Identifier: 21107287
author list: Blanchard EM, Moon J, Hesketh PJ, Kelly K, Wozniak AJ, Crowley J, Gandara D
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Blanchard EM, Moon J, Hesketh PJ, Kelly K, Wozniak AJ, Crowley J, Gandara D. Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509. J Thorac Oncol. 2011 Jan; 6(1):115-20.
journal title abbreviation: J Thorac Oncol
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Management of cisplatin-induced delayed emesis.
PubMed Identifier: 8692555
author list: Hesketh P
published in: Oncology
information resource reference: Hesketh P. Management of cisplatin-induced delayed emesis. Oncology. 1996 Jun; 53 Suppl 1:73-7.
journal title abbreviation: Oncology
publication date: 1996-06-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
PubMed Identifier: 33591844
author list: Hanna NH, Robinson AG, Temin S, Baker S, Brahmer JR, Ellis PM, Gaspar LE, Haddad RY, Hesketh PJ, Jain D, Jaiyesimi I, Johnson DH, Leighl NB, Moffitt PR, Phillips T, Riely GJ, Rosell R, Schiller JH, Schneider BJ, Singh N, Spigel DR, Tashbar J, Masters G
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hanna NH, Robinson AG, Temin S, Baker S, Brahmer JR, Ellis PM, Gaspar LE, Haddad RY, Hesketh PJ, Jain D, Jaiyesimi I, Johnson DH, Leighl NB, Moffitt PR, Phillips T, Riely GJ, Rosell R, Schiller JH, Schneider BJ, Singh N, Spigel DR, Tashbar J, Masters G. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. J Clin Oncol. 2021 03 20; 39(9):1040-1091.
journal title abbreviation: J Clin Oncol
publication date: 2021-02-16T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.
PubMed Identifier: 8000724
author list: Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ. Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists. Support Care Cancer. 1994 Sep; 2(5):286-92.
journal title abbreviation: Support Care Cancer
publication date: 1994-09-01T00:00:00
year: 1994
type: Academic Article
type: Article
type: Document
type: Information Resource

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
PubMed Identifier: 16314401
author list: Roila F, Hesketh PJ, Herrstedt J
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Roila F, Hesketh PJ, Herrstedt J. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol. 2006 Jan; 17(1):20-8.
journal title abbreviation: Ann Oncol
publication date: 2005-11-28T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
PubMed Identifier: 15510975
author list: Hesketh PJ
published in: Oncology (Williston Park, N.Y.)
information resource reference: Hesketh PJ. Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress. Oncology (Williston Park). 2004 Sep; 18(10 Suppl 6):9-14.
journal title abbreviation: Oncology (Williston Park)
publication date: 2004-09-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
PubMed Identifier: 15581051
author list: Safran H, Iannitti D, Ramanathan R, Schwartz JD, Steinhoff M, Nauman C, Hesketh P, Rathore R, Wolff R, Tantravahi U, Hughes TM, Maia C, Pasquariello T, Goldstein L, King T, Tsai JY, Kennedy T
published in: Cancer investigation
information resource reference: Safran H, Iannitti D, Ramanathan R, Schwartz JD, Steinhoff M, Nauman C, Hesketh P, Rathore R, Wolff R, Tantravahi U, Hughes TM, Maia C, Pasquariello T, Goldstein L, King T, Tsai JY, Kennedy T. Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu. Cancer Invest. 2004; 22(5):706-12.
journal title abbreviation: Cancer Invest
publication date: 2004-01-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
PubMed Identifier: 30481207
author list: Goldberg ME, Montesion M, Young L, Suh J, Greenbowe J, Kennedy M, Giaccone G, Akerley WL, Dowlati A, Creelan BC, Hicks JK, Hesketh PJ, Kelly KL, Riess JW, Miller VA, Stephens PJ, Frampton GM, Ali S, Gregg JP, Albacker LA
published in: PloS one
information resource reference: Goldberg ME, Montesion M, Young L, Suh J, Greenbowe J, Kennedy M, Giaccone G, Akerley WL, Dowlati A, Creelan BC, Hicks JK, Hesketh PJ, Kelly KL, Riess JW, Miller VA, Stephens PJ, Frampton GM, Ali S, Gregg JP, Albacker LA. Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC. PLoS One. 2018; 13(11):e0208097.
journal title abbreviation: PLoS One
publication date: 2018-11-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.
PubMed Identifier: 19066985
author list: Hesketh PJ, Younger J, Sanz-Altamira P, Hayden M, Bushey J, Trainor B, Krentzin M, Nowd P, Arnaoutakis K, Hesketh AM
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Younger J, Sanz-Altamira P, Hayden M, Bushey J, Trainor B, Krentzin M, Nowd P, Arnaoutakis K, Hesketh AM. Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide. Support Care Cancer. 2009 Aug; 17(8):1065-70.
journal title abbreviation: Support Care Cancer
publication date: 2008-12-06T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents.
PubMed Identifier: 27501965
author list: Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Warr D, Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Warr D, Hesketh PJ. 2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents. Support Care Cancer. 2017 01; 25(1):271-275.
journal title abbreviation: Support Care Cancer
publication date: 2016-08-08T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.
PubMed Identifier: 27510316
author list: Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B. 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy. Support Care Cancer. 2017 01; 25(1):289-294.
journal title abbreviation: Support Care Cancer
publication date: 2016-08-11T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.
PubMed Identifier: 38114821
author list: Scott? F, Schwartzberg L, Iihara H, Aapro M, Gralla R, Hesketh PJ, Jordan K, Chow R, Herrstedt J
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Scott? F, Schwartzberg L, Iihara H, Aapro M, Gralla R, Hesketh PJ, Jordan K, Chow R, Herrstedt J. 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Support Care Cancer. 2023 Dec 20; 32(1):45.
journal title abbreviation: Support Care Cancer
publication date: 2023-12-20T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.
PubMed Identifier: 38127246
author list: Herrstedt J, Celio L, Hesketh PJ, Zhang L, Navari R, Chan A, Saito M, Chow R, Aapro M
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Herrstedt J, Celio L, Hesketh PJ, Zhang L, Navari R, Chan A, Saito M, Chow R, Aapro M. 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Support Care Cancer. 2023 Dec 21; 32(1):47.
journal title abbreviation: Support Care Cancer
publication date: 2023-12-21T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
PubMed Identifier: 9552067
author list: Gralla RJ, Navari RM, Hesketh PJ, Popovic W, Strupp J, Noy J, Einhorn L, Ettinger D, Bushnell W, Friedman C
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Gralla RJ, Navari RM, Hesketh PJ, Popovic W, Strupp J, Noy J, Einhorn L, Ettinger D, Bushnell W, Friedman C. Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. J Clin Oncol. 1998 Apr; 16(4):1568-73.
journal title abbreviation: J Clin Oncol
publication date: 1998-04-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
PubMed Identifier: 21892109
author list: Sangha R, Davies AM, Lara PN, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Sangha R, Davies AM, Lara PN, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial. J Thorac Oncol. 2011 Dec; 6(12):2112-9.
journal title abbreviation: J Thorac Oncol
publication date: 2011-12-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.
PubMed Identifier: 9629873
author list: Hesketh PJ, Gralla RJ, du Bois A, Tonato M
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Gralla RJ, du Bois A, Tonato M. Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer. 1998 May; 6(3):221-7.
journal title abbreviation: Support Care Cancer
publication date: 1998-05-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Birth and re-birth.
PubMed Identifier: 18663480
author list: Grunberg SM, Herrstedt J, Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Grunberg SM, Herrstedt J, Hesketh PJ. Birth and re-birth. Support Care Cancer. 2008 Sep; 16(9):979.
journal title abbreviation: Support Care Cancer
publication date: 2008-09-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo.
PubMed Identifier: 8427724
author list: Gandara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Gandara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ. Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo. Eur J Cancer. 1993; 29A Suppl 1:S35-8.
journal title abbreviation: Eur J Cancer
publication date: 1993-01-01T00:00:00
year: 1993
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46847968
PubMed Identifier: 26370220
author list: Raftopoulos H, Laadem A, Hesketh PJ, Goldschmidt J, Gabrail N, Osborne C, Ali M, Sherman ML, Wang D, Glaspy JA, Puccio-Pick M, Zou J, Crawford J
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Raftopoulos H, Laadem A, Hesketh PJ, Goldschmidt J, Gabrail N, Osborne C, Ali M, Sherman ML, Wang D, Glaspy JA, Puccio-Pick M, Zou J, Crawford J. Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies. Support Care Cancer. 2016 Apr; 24(4):1517-25.
journal title abbreviation: Support Care Cancer
publication date: 2015-09-14T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.
PubMed Identifier: 20555089
author list: Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol. 2010 May; 21 Suppl 5:v232-43.
journal title abbreviation: Ann Oncol
publication date: 2010-05-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.
PubMed Identifier: 26476625
author list: Jordan K, Warr DG, Hinke A, Sun L, Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Jordan K, Warr DG, Hinke A, Sun L, Hesketh PJ. Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis. Support Care Cancer. 2016 May; 24(5):1941-1954.
journal title abbreviation: Support Care Cancer
publication date: 2015-10-17T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.
PubMed Identifier: 11291548
author list: Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen MH, Moore T, Koness J, Graziano S, Wanebo HJ
published in: Cancer investigation
information resource reference: Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen MH, Moore T, Koness J, Graziano S, Wanebo HJ. Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest. 2001; 19(1):1-7.
journal title abbreviation: Cancer Invest
publication date: 2001-01-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

The increasing frequency of adenocarcinoma of the esophagus.
PubMed Identifier: 2736498
author list: Hesketh PJ, Clapp RW, Doos WG, Spechler SJ
published in: Cancer
information resource reference: Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer. 1989 Jul 15; 64(2):526-30.
journal title abbreviation: Cancer
publication date: 1989-07-15T00:00:00
year: 1989
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.
PubMed Identifier: 27000465
author list: Aapro M, Hesketh PJ, Jordan K, Gralla RJ, Rossi G, Rizzi G, Palmas M
published in: The oncologist
information resource reference: Aapro M, Hesketh PJ, Jordan K, Gralla RJ, Rossi G, Rizzi G, Palmas M. Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program. Oncologist. 2016 Apr; 21(4):494-502.
journal title abbreviation: Oncologist
publication date: 2016-03-21T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
PubMed Identifier: 17409914
author list: Hesketh PJ, Chansky K, Lau DH, Doroshow JH, Moinpour CM, Chapman RA, Goodwin JW, Gross HM, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Hesketh PJ, Chansky K, Lau DH, Doroshow JH, Moinpour CM, Chapman RA, Goodwin JW, Gross HM, Crowley JJ, Gandara DR. Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027). J Thorac Oncol. 2006 Jul; 1(6):537-44.
journal title abbreviation: J Thorac Oncol
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
PubMed Identifier: 17409984
author list: Hesketh PJ, McCoy J, Dunphy FR, Bearden JD, Weiss GR, Giguere JK, Atkins JN, Dakhil SR, Kelly K, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Hesketh PJ, McCoy J, Dunphy FR, Bearden JD, Weiss GR, Giguere JK, Atkins JN, Dakhil SR, Kelly K, Crowley JJ, Gandara DR. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. J Thorac Oncol. 2006 Nov; 1(9):991-5.
journal title abbreviation: J Thorac Oncol
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Reply to J. Jupp et al.
PubMed Identifier: 27432934
author list: Hesketh PJ, Bohlke K, Kris MG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Bohlke K, Kris MG. Reply to J. Jupp et al. J Clin Oncol. 2016 09 20; 34(27):3353.
journal title abbreviation: J Clin Oncol
publication date: 2016-07-18T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy.
PubMed Identifier: 21553313
author list: Hesketh PJ, Sanz-Altamira P, Bushey J, Hesketh AM
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Sanz-Altamira P, Bushey J, Hesketh AM. Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy. Support Care Cancer. 2012 May; 20(5):1043-7.
journal title abbreviation: Support Care Cancer
publication date: 2011-05-09T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
PubMed Identifier: 10439170
author list: Hesketh PJ, Crowley JJ, Burris HA, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF, Livingston RB, Gandara DR
published in: The cancer journal from Scientific American
information resource reference: Hesketh PJ, Crowley JJ, Burris HA, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF, Livingston RB, Gandara DR. Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial. Cancer J Sci Am. 1999 Jul-Aug; 5(4):237-41.
journal title abbreviation: Cancer J Sci Am
publication date: 1999-07-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Lung cancer screening.
PubMed Identifier: 24189878
author list: Lamb CR, McKee AB, McKee BJ, Campagna A, Hesketh PJ
published in: Chest
information resource reference: Lamb CR, McKee AB, McKee BJ, Campagna A, Hesketh PJ. Lung cancer screening. Chest. 2013 Nov; 144(5):1737.
journal title abbreviation: Chest
publication date: 2013-11-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
PubMed Identifier: 10458252
author list: Hesketh PJ, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL. Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. J Clin Oncol. 1999 Jan; 17(1):338-43.
journal title abbreviation: J Clin Oncol
publication date: 1999-01-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
PubMed Identifier: 10561376
author list: Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999 Sep; 17(9):2971-94.
journal title abbreviation: J Clin Oncol
publication date: 1999-09-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.
PubMed Identifier: 17440682
author list: Davies AM, Ho C, Hesketh PJ, Beckett LA, Lara PN, Lau DH, Gandara DR
published in: Investigational new drugs
information resource reference: Davies AM, Ho C, Hesketh PJ, Beckett LA, Lara PN, Lau DH, Gandara DR. Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study. Invest New Drugs. 2007 Aug; 25(4):351-5.
journal title abbreviation: Invest New Drugs
publication date: 2007-04-18T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
PubMed Identifier: 17473660
author list: Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly K, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly K, Crowley JJ, Gandara DR. Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718. J Thorac Oncol. 2007 May; 2(5):440-4.
journal title abbreviation: J Thorac Oncol
publication date: 2007-05-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
PubMed Identifier: 10650897
author list: Hesketh PJ, Roman A, Hesketh AM, Perez EA, Edelman M, Gandara DR
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Roman A, Hesketh AM, Perez EA, Edelman M, Gandara DR. Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen. Support Care Cancer. 2000 Jan; 8(1):46-8.
journal title abbreviation: Support Care Cancer
publication date: 2000-01-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
PubMed Identifier: 10659396
author list: Rizk AN, Hesketh PJ
published in: Drugs in R&D
information resource reference: Rizk AN, Hesketh PJ. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development. Drugs R D. 1999 Oct; 2(4):229-35.
journal title abbreviation: Drugs R D
publication date: 1999-10-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic.
PubMed Identifier: 29080920
author list: Hesketh PJ, Palmas M, Nicolas P
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Palmas M, Nicolas P. Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic. Support Care Cancer. 2018 Apr; 26(4):1151-1159.
journal title abbreviation: Support Care Cancer
publication date: 2017-10-28T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Paclitaxel and concurrent radiation for gastric cancer.
PubMed Identifier: 10705010
author list: Safran H, Wanebo HJ, Hesketh PJ, Akerman P, Ianitti D, Cioffi W, DiPetrillo T, Wolf B, Koness J, McAnaw R, Moore T, Chen MH, Radie-Keane K
published in: International journal of radiation oncology, biology, physics
information resource reference: Safran H, Wanebo HJ, Hesketh PJ, Akerman P, Ianitti D, Cioffi W, DiPetrillo T, Wolf B, Koness J, McAnaw R, Moore T, Chen MH, Radie-Keane K. Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):889-94.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2000-03-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
PubMed Identifier: 7738628
author list: Navari R, Gandara D, Hesketh P, Hall S, Mailliard J, Ritter H, Friedman C, Fitts D
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Navari R, Gandara D, Hesketh P, Hall S, Mailliard J, Ritter H, Friedman C, Fitts D. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group. J Clin Oncol. 1995 May; 13(5):1242-8.
journal title abbreviation: J Clin Oncol
publication date: 1995-05-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
PubMed Identifier: 20972805
author list: Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K, Espersen BT
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K, Espersen BT. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art. Support Care Cancer. 2011 Mar; 19 Suppl 1:S43-7.
journal title abbreviation: Support Care Cancer
publication date: 2010-10-24T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
PubMed Identifier: 17545848
author list: Akerley W, McCoy J, Hesketh PJ, Goodwin JW, Bearden JD, Atkins JN, Chansky K, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Akerley W, McCoy J, Hesketh PJ, Goodwin JW, Bearden JD, Atkins JN, Chansky K, Crowley JJ, Gandara DR. Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119. J Thorac Oncol. 2007 Jun; 2(6):526-30.
journal title abbreviation: J Thorac Oncol
publication date: 2007-06-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.
PubMed Identifier: 27889278
author list: Aapro M, Jordan K, Gralla RJ, Rizzi G, Rossi G, Palmas M, Alyasova AV, Lisyanskaya AS, Bo?njak SM, Hesketh PJ
published in: Journal of geriatric oncology
information resource reference: Aapro M, Jordan K, Gralla RJ, Rizzi G, Rossi G, Palmas M, Alyasova AV, Lisyanskaya AS, Bo?njak SM, Hesketh PJ. Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients. J Geriatr Oncol. 2017 01; 8(1):56-63.
journal title abbreviation: J Geriatr Oncol
publication date: 2016-11-23T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.
PubMed Identifier: 29424580
author list: Hesketh PJ, Bohlke K, Kris MG
published in: Journal of oncology practice
information resource reference: Hesketh PJ, Bohlke K, Kris MG. Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Oncol Pract. 2016 Jan; 12(1):88-89.
journal title abbreviation: J Oncol Pract
publication date: 2016-01-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
PubMed Identifier: 28759346
author list: Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Oct 01; 35(28):3240-3261.
journal title abbreviation: J Clin Oncol
publication date: 2017-07-31T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
PubMed Identifier: 9917226
author list: Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh A, Kindler H, Grote TH, Pendergrass K, Grunberg SM, Carides AD, Gertz BJ
published in: The New England journal of medicine
information resource reference: Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh A, Kindler H, Grote TH, Pendergrass K, Grunberg SM, Carides AD, Gertz BJ. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. N Engl J Med. 1999 Jan 21; 340(3):190-5.
journal title abbreviation: N Engl J Med
publication date: 1999-01-21T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.
PubMed Identifier: 27624467
author list: Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B. Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy. Support Care Cancer. 2017 01; 25(1):295-296.
journal title abbreviation: Support Care Cancer
publication date: 2017-01-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848041
PubMed Identifier: 9070501
author list: Rubenstein EB, Gralla RJ, Hainsworth JD, Hesketh PJ, Grote TH, Modiano MR, Khojasteh A, Kalman LA, Benedict CR, Hahne WF
published in: Cancer
information resource reference: Rubenstein EB, Gralla RJ, Hainsworth JD, Hesketh PJ, Grote TH, Modiano MR, Khojasteh A, Kalman LA, Benedict CR, Hahne WF. Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group. Cancer. 1997 Mar 15; 79(6):1216-24.
journal title abbreviation: Cancer
publication date: 1997-03-15T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.

Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
PubMed Identifier: 10210540
author list: Safran H, Akerman P, Cioffi W, Gaissert H, Joseph P, King T, Hesketh PJ, Wanebo H
published in: Seminars in radiation oncology
information resource reference: Safran H, Akerman P, Cioffi W, Gaissert H, Joseph P, King T, Hesketh PJ, Wanebo H. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):53-7.
journal title abbreviation: Semin Radiat Oncol
publication date: 1999-04-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization.
PubMed Identifier: 19808165
author list: Ambika S, Melton A, Lee D, Hesketh PJ
published in: Clinical lung cancer
information resource reference: Ambika S, Melton A, Lee D, Hesketh PJ. Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization. Clin Lung Cancer. 2009 Sep; 10(5):E1-4.
journal title abbreviation: Clin Lung Cancer
publication date: 2009-09-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Proposal for classifying the acute emetogenicity of cancer chemotherapy.
PubMed Identifier: 8996130
author list: Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997 Jan; 15(1):103-9.
journal title abbreviation: J Clin Oncol
publication date: 1997-01-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.
PubMed Identifier: 8120559
author list: Hesketh PJ, Harvey WH, Harker WG, Beck TM, Ryan T, Bricker LJ, Kish JA, Murphy WK, Hainsworth JD, Haley B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Harvey WH, Harker WG, Beck TM, Ryan T, Bricker LJ, Kish JA, Murphy WK, Hainsworth JD, Haley B. A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol. 1994 Mar; 12(3):596-600.
journal title abbreviation: J Clin Oncol
publication date: 1994-03-01T00:00:00
year: 1994
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.
PubMed Identifier: 15599601
author list: Grunberg SM, Osoba D, Hesketh PJ, Gralla RJ, Borjeson S, Rapoport BL, du Bois A, Tonato M
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Grunberg SM, Osoba D, Hesketh PJ, Gralla RJ, Borjeson S, Rapoport BL, du Bois A, Tonato M. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update. Support Care Cancer. 2005 Feb; 13(2):80-4.
journal title abbreviation: Support Care Cancer
publication date: 2004-12-14T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Oral ondansetron: a useful addition to the supportive care armamentarium?
PubMed Identifier: 8141106
author list: Hesketh PJ
published in: American journal of clinical oncology
information resource reference: Hesketh PJ. Oral ondansetron: a useful addition to the supportive care armamentarium? Am J Clin Oncol. 1994 Apr; 17(2):147-9.
journal title abbreviation: Am J Clin Oncol
publication date: 1994-04-01T00:00:00
year: 1994
type: Academic Article
type: Article
type: Document
type: Information Resource

Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
PubMed Identifier: 9161784
author list: Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD
published in: The cancer journal from Scientific American
information resource reference: Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone. Cancer J Sci Am. 1997 May-Jun; 3(3):180-3.
journal title abbreviation: Cancer J Sci Am
publication date: 1997-05-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy.
PubMed Identifier: 21976035
author list: Hesketh PJ, Bosnjak SM, Nikolic V, Rapoport B
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Bosnjak SM, Nikolic V, Rapoport B. Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy. Support Care Cancer. 2011 Dec; 19(12):2063-6.
journal title abbreviation: Support Care Cancer
publication date: 2011-12-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
PubMed Identifier: 9166505
author list: Burris H, Hesketh P, Cohn J, Moriconi W, Ryan T, Friedman C, Fitts D
published in: The cancer journal from Scientific American
information resource reference: Burris H, Hesketh P, Cohn J, Moriconi W, Ryan T, Friedman C, Fitts D. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy. Cancer J Sci Am. 1996 Mar-Apr; 2(2):85-90.
journal title abbreviation: Cancer J Sci Am
publication date: 1996-03-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin.
PubMed Identifier: 9182982
author list: Kris MG, Radford JE, Pizzo BA, Inabinet R, Hesketh A, Hesketh PJ
published in: Journal of the National Cancer Institute
information resource reference: Kris MG, Radford JE, Pizzo BA, Inabinet R, Hesketh A, Hesketh PJ. Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin. J Natl Cancer Inst. 1997 Jun 04; 89(11):817-8.
journal title abbreviation: J Natl Cancer Inst
publication date: 1997-06-04T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma.
PubMed Identifier: 8355035
author list: Hesketh P, Caguioa P, Koh H, Dewey H, Facada A, McCaffrey R, Parker K, Nylen P, Woodworth T
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh P, Caguioa P, Koh H, Dewey H, Facada A, McCaffrey R, Parker K, Nylen P, Woodworth T. Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma. J Clin Oncol. 1993 Sep; 11(9):1682-90.
journal title abbreviation: J Clin Oncol
publication date: 1993-09-01T00:00:00
year: 1993
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.
PubMed Identifier: 8381703
author list: Hesketh PJ, Tansan S, Caguioa PB, Hesketh A, Blanchard R, DiMartino N, Carney D
published in: Cancer
information resource reference: Hesketh PJ, Tansan S, Caguioa PB, Hesketh A, Blanchard R, DiMartino N, Carney D. Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C. Cancer. 1993 Feb 01; 71(3):717-20.
journal title abbreviation: Cancer
publication date: 1993-02-01T00:00:00
year: 1993
type: Academic Article
type: Article
type: Document
type: Information Resource

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation.
PubMed Identifier: 38129530
author list: Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Ruhlmann CH, Sayegh P, Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Ruhlmann CH, Sayegh P, Hesketh PJ. Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation. Support Care Cancer. 2023 Dec 22; 32(1):53.
journal title abbreviation: Support Care Cancer
publication date: 2023-12-22T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.
PubMed Identifier: 1387248
author list: Hesketh PJ
published in: Seminars in oncology
information resource reference: Hesketh PJ. Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis. Semin Oncol. 1992 Aug; 19(4 Suppl 10):33-40.
journal title abbreviation: Semin Oncol
publication date: 1992-08-01T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource

The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
PubMed Identifier: 1387253
author list: Gandara DR, Harvey WH, Monaghan GG, Perez EA, Stokes C, Bryson JC, Finn AL, Hesketh PJ
published in: Seminars in oncology
information resource reference: Gandara DR, Harvey WH, Monaghan GG, Perez EA, Stokes C, Bryson JC, Finn AL, Hesketh PJ. The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo. Semin Oncol. 1992 Aug; 19(4 Suppl 10):67-71.
journal title abbreviation: Semin Oncol
publication date: 1992-08-01T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
PubMed Identifier: 16717289
author list: Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006 Jun 20; 24(18):2932-47.
journal title abbreviation: J Clin Oncol
publication date: 2006-05-22T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
PubMed Identifier: 21947834
author list: Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011 Nov 01; 29(31):4189-98.
journal title abbreviation: J Clin Oncol
publication date: 2011-09-26T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting.
PubMed Identifier: 22089429
author list: Hesketh PJ, Sanz-Altamira P
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Sanz-Altamira P. Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting. Support Care Cancer. 2012 Mar; 20(3):653-6.
journal title abbreviation: Support Care Cancer
publication date: 2011-11-18T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848086
PubMed Identifier: 1826739
author list: Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G, et al. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol. 1991 May; 9(5):721-8.
journal title abbreviation: J Clin Oncol
publication date: 1991-05-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource
label: A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

Serotonin antagonists in the management of cisplatin-induced emesis.
PubMed Identifier: 2003230
author list: Perez EA, Hesketh PJ, Gandara DR
published in: Seminars in oncology
information resource reference: Perez EA, Hesketh PJ, Gandara DR. Serotonin antagonists in the management of cisplatin-induced emesis. Semin Oncol. 1991 Feb; 18(1 Suppl 3):73-80.
journal title abbreviation: Semin Oncol
publication date: 1991-02-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Role of adjuvant therapy in colorectal cancer.
PubMed Identifier: 2024581
author list: Hesketh PJ, Bulger KN
published in: Advances in internal medicine
information resource reference: Hesketh PJ, Bulger KN. Role of adjuvant therapy in colorectal cancer. Adv Intern Med. 1991; 36:219-47.
journal title abbreviation: Adv Intern Med
publication date: 1991-01-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting.
PubMed Identifier: 26421300
author list: Hesketh PJ, Aapro M, Jordan K, Schwartzberg L, Bosnjak S, Rugo H
published in: BioMed research international
information resource reference: Hesketh PJ, Aapro M, Jordan K, Schwartzberg L, Bosnjak S, Rugo H. A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting. Biomed Res Int. 2015; 2015:651879.
journal title abbreviation: Biomed Res Int
publication date: 2015-09-03T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
PubMed Identifier: 35816666
author list: Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. J Clin Oncol. 2022 10 01; 40(28):3310-3322.
journal title abbreviation: J Clin Oncol
publication date: 2022-07-11T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
PubMed Identifier: 35816668
author list: Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. J Clin Oncol. 2022 10 01; 40(28):3323-3343.
journal title abbreviation: J Clin Oncol
publication date: 2022-07-11T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics: American Society of Clinical Oncology Focused Guideline Update.
PubMed Identifier: 26527784
author list: Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Bohlke K, Lyman GH, Basch E, Chesney M, Clark-Snow RA, Danso MA, Jordan K, Somerfield MR, Kris MG. Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Clin Oncol. 2016 Feb 01; 34(4):381-6.
journal title abbreviation: J Clin Oncol
publication date: 2015-11-02T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.
PubMed Identifier: 11781617
author list: Ballen KK, Hesketh AM, Heyes C, Becker PS, Emmons RV, Fogarty K, LaPointe J, Liu Q, Hsieh CC, Hesketh PJ
published in: Bone marrow transplantation
information resource reference: Ballen KK, Hesketh AM, Heyes C, Becker PS, Emmons RV, Fogarty K, LaPointe J, Liu Q, Hsieh CC, Hesketh PJ. Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support. Bone Marrow Transplant. 2001 Dec; 28(11):1061-6.
journal title abbreviation: Bone Marrow Transplant
publication date: 2001-12-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848103
PubMed Identifier: 21822913
author list: Hesketh PJ, Wright O, Rosati G, Russo M, Levin J, Lane S, Moiseyenko V, Dube P, Kopp M, Makhson A
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Wright O, Rosati G, Russo M, Levin J, Lane S, Moiseyenko V, Dube P, Kopp M, Makhson A. Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study. Support Care Cancer. 2012 Jul; 20(7):1471-8.
journal title abbreviation: Support Care Cancer
publication date: 2011-08-07T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.

https://profiles.umassmed.edu/profile/46848104
PubMed Identifier: 26725184
author list: Lara PN, Moon J, Hesketh PJ, Redman MW, Williamson SK, Akerley WL, Hirsch FR, Mack PC, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Lara PN, Moon J, Hesketh PJ, Redman MW, Williamson SK, Akerley WL, Hirsch FR, Mack PC, Gandara DR. SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. J Thorac Oncol. 2016 Mar; 11(3):420-5.
journal title abbreviation: J Thorac Oncol
publication date: 2015-12-25T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource
label: SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.

Antiemetics: ASCO Guideline Update.
PubMed Identifier: 32658626
author list: Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Lyman GH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Lyman GH. Antiemetics: ASCO Guideline Update. J Clin Oncol. 2020 08 20; 38(24):2782-2797.
journal title abbreviation: J Clin Oncol
publication date: 2020-07-13T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.
PubMed Identifier: 27443154
author list: Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS. 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy. Support Care Cancer. 2017 01; 25(1):277-288.
journal title abbreviation: Support Care Cancer
publication date: 2016-07-22T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials.
PubMed Identifier: 9773466
author list: Whitmore JB, Kris MG, Hesketh PJ, Grote TH, DuBois DM, Cramer MB, Hahne WF
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Whitmore JB, Kris MG, Hesketh PJ, Grote TH, DuBois DM, Cramer MB, Hahne WF. Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trials. Support Care Cancer. 1998 Sep; 6(5):473-8.
journal title abbreviation: Support Care Cancer
publication date: 1998-09-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Cannabinoids as antiemetics: everything that's old is new again.
PubMed Identifier: 32860877
author list: Warr D, Hesketh P
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Warr D, Hesketh P. Cannabinoids as antiemetics: everything that's old is new again. Ann Oncol. 2020 11; 31(11):1425-1426.
journal title abbreviation: Ann Oncol
publication date: 2020-08-26T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
PubMed Identifier: 28806116
author list: Hanna N, Johnson D, Temin S, Baker S, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Smith TJ, Tashbar J, Biermann WA, Masters G
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hanna N, Johnson D, Temin S, Baker S, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Smith TJ, Tashbar J, Biermann WA, Masters G. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Oct 20; 35(30):3484-3515.
journal title abbreviation: J Clin Oncol
publication date: 2017-08-14T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.
PubMed Identifier: 9072308
author list: Grote TH, Pineda LF, Figlin RA, Pendergrass KB, Hesketh PJ, Karlan BY, Reeves JA, Porter LL, Benedict CR, Hahne WF
published in: The cancer journal from Scientific American
information resource reference: Grote TH, Pineda LF, Figlin RA, Pendergrass KB, Hesketh PJ, Karlan BY, Reeves JA, Porter LL, Benedict CR, Hahne WF. Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group. Cancer J Sci Am. 1997 Jan-Feb; 3(1):45-51.
journal title abbreviation: Cancer J Sci Am
publication date: 1997-01-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Drug treatment of chemotherapy-induced delayed emesis.
PubMed Identifier: 9118814
author list: Tavorath R, Hesketh PJ
published in: Drugs
information resource reference: Tavorath R, Hesketh PJ. Drug treatment of chemotherapy-induced delayed emesis. Drugs. 1996 Nov; 52(5):639-48.
journal title abbreviation: Drugs
publication date: 1996-11-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
PubMed Identifier: 27664248
author list: Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol. 2016 Sep; 27(suppl 5):v119-v133.
journal title abbreviation: Ann Oncol
publication date: 2016-09-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
PubMed Identifier: 10394587
author list: Hesketh PJ
published in: The oncologist
information resource reference: Hesketh PJ. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist. 1999; 4(3):191-6.
journal title abbreviation: Oncologist
publication date: 1999-01-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in Cancer.
PubMed Identifier: 9257422
author list: Ballatori E, Roila F, De Angelis V, Ciccarese G, Palladino MA, Tonato M, Del Favero A, Herrstedt J, Dicato M, du Bois A, Hesketh P, Kris M, Gralla RJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Ballatori E, Roila F, De Angelis V, Ciccarese G, Palladino MA, Tonato M, Del Favero A, Herrstedt J, Dicato M, du Bois A, Hesketh P, Kris M, Gralla RJ. Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Multinational Association of Supportive Care in Cancer. Support Care Cancer. 1997 Jul; 5(4):269-73.
journal title abbreviation: Support Care Cancer
publication date: 1997-07-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848123
PubMed Identifier: 9469367
author list: Perez EA, Hesketh P, Sandbach J, Reeves J, Chawla S, Markman M, Hainsworth J, Bushnell W, Friedman C
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Perez EA, Hesketh P, Sandbach J, Reeves J, Chawla S, Markman M, Hainsworth J, Bushnell W, Friedman C. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. J Clin Oncol. 1998 Feb; 16(2):754-60.
journal title abbreviation: J Clin Oncol
publication date: 1998-02-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
PubMed Identifier: 28968170
author list: Kim ES, Bruinooge SS, Roberts S, Ison G, Lin NU, Gore L, Uldrick TS, Lichtman SM, Roach N, Beaver JA, Sridhara R, Hesketh PJ, Denicoff AM, Garrett-Mayer E, Rubin E, Multani P, Prowell TM, Schenkel C, Kozak M, Allen J, Sigal E, Schilsky RL
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Kim ES, Bruinooge SS, Roberts S, Ison G, Lin NU, Gore L, Uldrick TS, Lichtman SM, Roach N, Beaver JA, Sridhara R, Hesketh PJ, Denicoff AM, Garrett-Mayer E, Rubin E, Multani P, Prowell TM, Schenkel C, Kozak M, Allen J, Sigal E, Schilsky RL. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. J Clin Oncol. 2017 Nov 20; 35(33):3737-3744.
journal title abbreviation: J Clin Oncol
publication date: 2017-10-02T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
PubMed Identifier: 31990617
author list: Hanna NH, Schneider BJ, Temin S, Baker S, Brahmer J, Ellis PM, Gaspar LE, Haddad RY, Hesketh PJ, Jain D, Jaiyesimi I, Johnson DH, Leighl NB, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Singh N, Spigel DR, Stabler JO, Tashbar J, Masters G
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hanna NH, Schneider BJ, Temin S, Baker S, Brahmer J, Ellis PM, Gaspar LE, Haddad RY, Hesketh PJ, Jain D, Jaiyesimi I, Johnson DH, Leighl NB, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Singh N, Spigel DR, Stabler JO, Tashbar J, Masters G. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. J Clin Oncol. 2020 05 10; 38(14):1608-1632.
journal title abbreviation: J Clin Oncol
publication date: 2020-01-28T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.
PubMed Identifier: 28981389
author list: Smith TJ, Hanna N, Johnson D, Baker S, Biermann WA, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Tashbar J, Temin S, Masters G
published in: Journal of oncology practice
information resource reference: Smith TJ, Hanna N, Johnson D, Baker S, Biermann WA, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Tashbar J, Temin S, Masters G. Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients. J Oncol Pract. 2017 12; 13(12):780-783.
journal title abbreviation: J Oncol Pract
publication date: 2017-10-05T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
PubMed Identifier: 7570050
author list: Hesketh P
published in: Seminars in oncology
information resource reference: Hesketh P. Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy. Semin Oncol. 1995 Aug; 22(4 Suppl 10):19-23.
journal title abbreviation: Semin Oncol
publication date: 1995-08-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting.
PubMed Identifier: 10705879
author list: Hesketh PJ
published in: Cancer investigation
information resource reference: Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting. Cancer Invest. 2000; 18(2):163-73.
journal title abbreviation: Cancer Invest
publication date: 2000-01-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
PubMed Identifier: 7636556
author list: Hesketh PJ, Beck T, Uhlenhopp M, Kris MG, Hainsworth JD, Harker WG, Cohen JR, Lester E, Kessler JF, Griffen D
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Beck T, Uhlenhopp M, Kris MG, Hainsworth JD, Harker WG, Cohen JR, Lester E, Kessler JF, Griffen D, et al. Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen. J Clin Oncol. 1995 Aug; 13(8):2117-22.
journal title abbreviation: J Clin Oncol
publication date: 1995-08-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
PubMed Identifier: 17545843
author list: Hesketh PJ, Lilenbaum RC, Chansky K, Dowlati A, Graham P, Chapman RA, Crowley JJ, Gandara DR
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Hesketh PJ, Lilenbaum RC, Chansky K, Dowlati A, Graham P, Chapman RA, Crowley JJ, Gandara DR. Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6. J Thorac Oncol. 2007 Jun; 2(6):494-8.
journal title abbreviation: J Thorac Oncol
publication date: 2007-06-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO.
PubMed Identifier: 24451791
author list: Basch E, Prestrud AA, Hesketh PJ, Kris MG, Somerfield MR, Lyman GH
published in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
information resource reference: Basch E, Prestrud AA, Hesketh PJ, Kris MG, Somerfield MR, Lyman GH. Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO. Am Soc Clin Oncol Educ Book. 2012; 532-40.
journal title abbreviation: Am Soc Clin Oncol Educ Book
publication date: 2012-01-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.
PubMed Identifier: 10882331
author list: Hesketh PJ, Crews JR, Cohen R, Blackburn LM, Friedman CJ
published in: Cancer journal (Sudbury, Mass.)
information resource reference: Hesketh PJ, Crews JR, Cohen R, Blackburn LM, Friedman CJ. Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy. Cancer J. 2000 May-Jun; 6(3):157-61.
journal title abbreviation: Cancer J
publication date: 2000-05-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence.
PubMed Identifier: 11013282
author list: Ioannidis JP, Hesketh PJ, Lau J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Ioannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol. 2000 Oct 01; 18(19):3409-22.
journal title abbreviation: J Clin Oncol
publication date: 2000-10-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Breast cancer in elderly women: presentation, survival, and treatment options.
PubMed Identifier: 8610265
author list: Law TM, Hesketh PJ, Porter KA, Lawn-Tsao L, McAnaw R, Lopez MJ
published in: The Surgical clinics of North America
information resource reference: Law TM, Hesketh PJ, Porter KA, Lawn-Tsao L, McAnaw R, Lopez MJ. Breast cancer in elderly women: presentation, survival, and treatment options. Surg Clin North Am. 1996 Apr; 76(2):289-308.
journal title abbreviation: Surg Clin North Am
publication date: 1996-04-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
PubMed Identifier: 18632487
author list: Reddy GK, Gralla RJ, Hesketh PJ
published in: Supportive cancer therapy
information resource reference: Reddy GK, Gralla RJ, Hesketh PJ. Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Support Cancer Ther. 2006 Apr 01; 3(3):140-2.
journal title abbreviation: Support Cancer Ther
publication date: 2006-04-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide.
PubMed Identifier: 8673351
author list: Hesketh PJ, Gandara DR, Hesketh AM, Facada A, Perez EA, Webber LM, Martin LA, Cramer MB, Hahne WF
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Gandara DR, Hesketh AM, Facada A, Perez EA, Webber LM, Martin LA, Cramer MB, Hahne WF. Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide. Support Care Cancer. 1996 Mar; 4(2):141-6.
journal title abbreviation: Support Care Cancer
publication date: 1996-03-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Control of chemotherapy-induced emesis.
PubMed Identifier: 8232489
author list: Grunberg SM, Hesketh PJ
published in: The New England journal of medicine
information resource reference: Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med. 1993 Dec 09; 329(24):1790-6.
journal title abbreviation: N Engl J Med
publication date: 1993-12-09T00:00:00
year: 1993
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
PubMed Identifier: 15837996
author list: Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol. 2005 Apr 20; 23(12):2822-30.
journal title abbreviation: J Clin Oncol
publication date: 2005-04-20T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Acute emesis: moderately emetogenic chemotherapy.
PubMed Identifier: 15565276
author list: Herrstedt J, Koeller JM, Roila F, Hesketh PJ, Warr D, Rittenberg C, Dicato M
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Herrstedt J, Koeller JM, Roila F, Hesketh PJ, Warr D, Rittenberg C, Dicato M. Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer. 2005 Feb; 13(2):97-103.
journal title abbreviation: Support Care Cancer
publication date: 2004-11-23T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
PubMed Identifier: 15939263
author list: Warr DG, Grunberg SM, Gralla RJ, Hesketh PJ, Roila F, Wit Rd, Carides AD, Taylor A, Evans JK, Horgan KJ
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Warr DG, Grunberg SM, Gralla RJ, Hesketh PJ, Roila F, Wit Rd, Carides AD, Taylor A, Evans JK, Horgan KJ. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials. Eur J Cancer. 2005 Jun; 41(9):1278-85.
journal title abbreviation: Eur J Cancer
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.
PubMed Identifier: 8208519
author list: Tansan S, Emri S, Sel?uk T, Ko? Y, Hesketh P, Heeren T, McCaffrey RP, Baris YI
published in: Oncology
information resource reference: Tansan S, Emri S, Sel?uk T, Ko? Y, Hesketh P, Heeren T, McCaffrey RP, Baris YI. Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon. Oncology. 1994 Jul-Aug; 51(4):348-51.
journal title abbreviation: Oncology
publication date: 1994-07-01T00:00:00
year: 1994
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetics: american society of clinical oncology clinical practice guideline update.
PubMed Identifier: 22379425
author list: Basch E, Hesketh PJ, Kris MG, Prestrud AA, Temin S, Lyman GH
published in: Journal of oncology practice
information resource reference: Basch E, Hesketh PJ, Kris MG, Prestrud AA, Temin S, Lyman GH. Antiemetics: american society of clinical oncology clinical practice guideline update. J Oncol Pract. 2011 Nov; 7(6):395-8.
journal title abbreviation: J Oncol Pract
publication date: 2011-10-21T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
PubMed Identifier: 29496255
author list: Gerber DE, Socinski MA, Neal JW, Wakelee HA, Shirai K, Sequist LV, Rosovsky RP, Lilenbaum RC, Bastos BR, Huang C, Johnson ML, Hesketh PJ, Subramaniam DS, Dietrich MF, Chai F, Wang Y, Kazakin J, Schwartz B, Schiller JH, Brahmer JR, Kelly RJ
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Gerber DE, Socinski MA, Neal JW, Wakelee HA, Shirai K, Sequist LV, Rosovsky RP, Lilenbaum RC, Bastos BR, Huang C, Johnson ML, Hesketh PJ, Subramaniam DS, Dietrich MF, Chai F, Wang Y, Kazakin J, Schwartz B, Schiller JH, Brahmer JR, Kelly RJ. Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. Lung Cancer. 2018 03; 117:44-49.
journal title abbreviation: Lung Cancer
publication date: 2018-02-03T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
PubMed Identifier: 15565277
author list: Kris MG, Hesketh PJ, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Koeller J, Olver I, Borjeson S, Ballatori E
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Kris MG, Hesketh PJ, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Koeller J, Olver I, Borjeson S, Ballatori E. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer. 2005 Feb; 13(2):85-96.
journal title abbreviation: Support Care Cancer
publication date: 2004-11-23T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Uncommon hematologic malignancies. Case 2. Calcification in untreated primary mediastinal large B-cell lymphoma with sclerosis.
PubMed Identifier: 14615456
author list: Oo TH, Aish LS, Schneider D, Hesketh PJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Oo TH, Aish LS, Schneider D, Hesketh PJ. Uncommon hematologic malignancies. Case 2. Calcification in untreated primary mediastinal large B-cell lymphoma with sclerosis. J Clin Oncol. 2003 Nov 15; 21(22):4249-51.
journal title abbreviation: J Clin Oncol
publication date: 2003-11-15T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848164
PubMed Identifier: 14559886
author list: Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, Evans JK, Beck K, Reines S, Horgan KJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, Evans JK, Beck K, Reines S, Horgan KJ. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group. J Clin Oncol. 2003 Nov 15; 21(22):4112-9.
journal title abbreviation: J Clin Oncol
publication date: 2003-10-14T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource
label: The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Lung cancer in octogenarians.
PubMed Identifier: 20521358
author list: Blanchard EM, Arnaoutakis K, Hesketh PJ
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Blanchard EM, Arnaoutakis K, Hesketh PJ. Lung cancer in octogenarians. J Thorac Oncol. 2010 Jun; 5(6):909-16.
journal title abbreviation: J Thorac Oncol
publication date: 2010-06-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Serotonin antagonists: a new class of antiemetic agents.
PubMed Identifier: 1850806
author list: Hesketh PJ, Gandara DR
published in: Journal of the National Cancer Institute
information resource reference: Hesketh PJ, Gandara DR. Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst. 1991 May 01; 83(9):613-20.
journal title abbreviation: J Natl Cancer Inst
publication date: 1991-05-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.
PubMed Identifier: 12736106
author list: Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer. 2003 May; 39(8):1074-80.
journal title abbreviation: Eur J Cancer
publication date: 2003-05-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.
PubMed Identifier: 16104039
author list: Herrstedt J, Muss HB, Warr DG, Hesketh PJ, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Hustad CM, Horgan KJ, Skobieranda F
published in: Cancer
information resource reference: Herrstedt J, Muss HB, Warr DG, Hesketh PJ, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Hustad CM, Horgan KJ, Skobieranda F. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer. 2005 Oct 01; 104(7):1548-55.
journal title abbreviation: Cancer
publication date: 2005-10-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC).
PubMed Identifier: 20623144
author list: Hesketh PJ, Warr DG, Street JC, Carides AD
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Warr DG, Street JC, Carides AD. Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC). Support Care Cancer. 2011 Sep; 19(9):1297-302.
journal title abbreviation: Support Care Cancer
publication date: 2010-07-11T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results.
PubMed Identifier: 1485176
author list: Hainsworth JD, Hesketh PJ
published in: Seminars in oncology
information resource reference: Hainsworth JD, Hesketh PJ. Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results. Semin Oncol. 1992 Dec; 19(6 Suppl 15):14-9.
journal title abbreviation: Semin Oncol
publication date: 1992-12-01T00:00:00
year: 1992
type: Academic Article
type: Article
type: Document
type: Information Resource

Penny wise, dollar foolish approach to antiemetic use may compromise patient care.
PubMed Identifier: 20856731
author list: Hesketh PJ
published in: Journal of oncology practice
information resource reference: Hesketh PJ. Penny wise, dollar foolish approach to antiemetic use may compromise patient care. J Oncol Pract. 2009 Sep; 5(5):221-2.
journal title abbreviation: J Oncol Pract
publication date: 2009-09-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
PubMed Identifier: 37294262
author list: Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, Feldman J, Gomez DR, Hesketh PJ, Jabbour SK, Jeter M, Josipovic M, Lievens Y, McDonald F, Perez BA, Ricardi U, Ruffini E, De Ruysscher D, Saeed H, Schneider BJ, Senan S, Widder J, Guckenberger M
published in: Practical radiation oncology
information resource reference: Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, Feldman J, Gomez DR, Hesketh PJ, Jabbour SK, Jeter M, Josipovic M, Lievens Y, McDonald F, Perez BA, Ricardi U, Ruffini E, De Ruysscher D, Saeed H, Schneider BJ, Senan S, Widder J, Guckenberger M. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023 Sep-Oct; 13(5):393-412.
journal title abbreviation: Pract Radiat Oncol
publication date: 2023-04-25T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
PubMed Identifier: 2479778
author list: Bulger KN, Hesketh PJ, Babayan RK
published in: The Journal of urology
information resource reference: Bulger KN, Hesketh PJ, Babayan RK. Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer. J Urol. 1989 Dec; 142(6):1574-5.
journal title abbreviation: J Urol
publication date: 1989-12-01T00:00:00
year: 1989
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848188
PubMed Identifier: 24608196
author list: Hesketh PJ, Rossi G, Rizzi G, Palmas M, Alyasova A, Bondarenko I, Lisyanskaya A, Gralla RJ
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Hesketh PJ, Rossi G, Rizzi G, Palmas M, Alyasova A, Bondarenko I, Lisyanskaya A, Gralla RJ. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Ann Oncol. 2014 Jul; 25(7):1340-1346.
journal title abbreviation: Ann Oncol
publication date: 2014-03-07T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.
PubMed Identifier: 2523957
author list: Hesketh PJ, Murphy WK, Lester EP, Gandara DR, Khojasteh A, Tapazoglou E, Sartiano GP, White DR, Werner K, Chubb JM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh PJ, Murphy WK, Lester EP, Gandara DR, Khojasteh A, Tapazoglou E, Sartiano GP, White DR, Werner K, Chubb JM. GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis. J Clin Oncol. 1989 Jun; 7(6):700-5.
journal title abbreviation: J Clin Oncol
publication date: 1989-06-01T00:00:00
year: 1989
type: Academic Article
type: Article
type: Document
type: Information Resource

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
PubMed Identifier: 12712486
author list: Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ
published in: Cancer
information resource reference: Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer. 2003 May 01; 97(9):2290-300.
journal title abbreviation: Cancer
publication date: 2003-05-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?
PubMed Identifier: 16354308
author list: Gandara DR, Hesketh P
published in: Clinical lung cancer
information resource reference: Gandara DR, Hesketh P. Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"? Clin Lung Cancer. 2005 Nov; 7(3):154-5.
journal title abbreviation: Clin Lung Cancer
publication date: 2005-11-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C.
PubMed Identifier: 2844381
author list: Hesketh PJ, Cooley TP, Finkel HE, Wright J, Hesketh AM
published in: Cancer
information resource reference: Hesketh PJ, Cooley TP, Finkel HE, Wright J, Hesketh AM. Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C. Cancer. 1988 Oct 15; 62(8):1466-70.
journal title abbreviation: Cancer
publication date: 1988-10-15T00:00:00
year: 1988
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848197
PubMed Identifier: 19756774
author list: Hesketh PJ, Aapro M, Street JC, Carides AD
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Aapro M, Street JC, Carides AD. Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy. Support Care Cancer. 2010 Sep; 18(9):1171-7.
journal title abbreviation: Support Care Cancer
publication date: 2009-09-12T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy.

https://profiles.umassmed.edu/profile/46848198
PubMed Identifier: 8708713
author list: Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, Anthony L, Khojasteh A, Tapazoglou E, Benedict C, Hahne W
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, Anthony L, Khojasteh A, Tapazoglou E, Benedict C, Hahne W. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. J Clin Oncol. 1996 Aug; 14(8):2242-9.
journal title abbreviation: J Clin Oncol
publication date: 1996-08-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
PubMed Identifier: 28837374
author list: Hesketh PJ, Bohlke K, Kris MG
published in: Journal of oncology practice
information resource reference: Hesketh PJ, Bohlke K, Kris MG. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Summary. J Oncol Pract. 2017 12; 13(12):825-830.
journal title abbreviation: J Oncol Pract
publication date: 2017-08-24T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

https://profiles.umassmed.edu/profile/46848201
PubMed Identifier: 16450086
author list: Hesketh PJ, Grunberg SM, Herrstedt J, de Wit R, Gralla RJ, Carides AD, Taylor A, Evans JK, Horgan KJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ, Grunberg SM, Herrstedt J, de Wit R, Gralla RJ, Carides AD, Taylor A, Evans JK, Horgan KJ. Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response. Support Care Cancer. 2006 Apr; 14(4):354-60.
journal title abbreviation: Support Care Cancer
publication date: 2006-02-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
PubMed Identifier: 27176138
author list: Hesketh PJ, Schnadig ID, Schwartzberg LS, Modiano MR, Jordan K, Arora S, Powers D, Aapro M
published in: Cancer
information resource reference: Hesketh PJ, Schnadig ID, Schwartzberg LS, Modiano MR, Jordan K, Arora S, Powers D, Aapro M. Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy. Cancer. 2016 Aug 01; 122(15):2418-25.
journal title abbreviation: Cancer
publication date: 2016-05-13T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Martinez, Fernando
first name: Fernando
last name: Martinez
full name: Fernando J Martinez MD, MS
has faculty rank: Professor
latitude: 42.27525000000000
longitude: -71.76233800000000
Person ID: 10247895
person in primary position: Professor
type: Agent
type: Person
Endowed Chair Honorary Title: Joseph D. Early Chair in Biomedical Research
preferred title: Professor

Professor
is primary position: true
position in department: Medicine
position in division: Pulmonary Medicine
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

Authorship 121498
type: Authorship
author rank in publication: 1
linked author: Hesketh, Paul
linked information resource: Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.

Authorship 121500
type: Authorship
author rank in publication: 5
linked author: Hesketh, Paul
linked information resource: Antiemetic guidelines: creating a more practical treatment approach.

Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.
PubMed Identifier: 11497388
author list: Hesketh PJ
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Hesketh PJ. Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting. Support Care Cancer. 2001 Jul; 9(5):350-4.
journal title abbreviation: Support Care Cancer
publication date: 2001-07-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Antiemetic guidelines: creating a more practical treatment approach.
PubMed Identifier: 12324805
author list: Koeller JM, Aapro MS, Gralla RJ, Grunberg SM, Hesketh PJ, Kris MG, Clark-Snow RA
published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
information resource reference: Koeller JM, Aapro MS, Gralla RJ, Grunberg SM, Hesketh PJ, Kris MG, Clark-Snow RA. Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer. 2002 Oct; 10(7):519-22.
journal title abbreviation: Support Care Cancer
publication date: 2002-02-21T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Instructor
sort order: 17
type: Faculty Rank

Professor
sort order: 3
type: Faculty Rank

Assistant Professor
sort order: 13
type: Faculty Rank

Associate Professor
sort order: 10
type: Faculty Rank

Chair And Professor
sort order: 4
type: Faculty Rank

Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.
PubMed Identifier: 9060526
author list: Safran H, King TP, Choy H, Hesketh PJ, Wolf B, Altenhein E, Sikov W, Rosmarin A, Akerley W, Radie-Keane K, Cicchetti G, Lopez F, Bland K, Wanebo HJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Safran H, King TP, Choy H, Hesketh PJ, Wolf B, Altenhein E, Sikov W, Rosmarin A, Akerley W, Radie-Keane K, Cicchetti G, Lopez F, Bland K, Wanebo HJ. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol. 1997 Mar; 15(3):901-7.
journal title abbreviation: J Clin Oncol
publication date: 1997-03-01T00:00:00
year: 1997
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor
is primary position: true
position in department: Medicine
position in division: Health System Science
sort order: 1
type: Position
HR job title: Associate Professor
position in organization: UMass Chan Medical School

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Piper-Vallillo, Andrew
first name: Andrew
last name: Piper-Vallillo
full name: Andrew J Piper-Vallillo MD
has faculty rank: Assistant Professor
Person ID: 10248351
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Authorship 132684
type: Authorship
author rank in publication: 4
linked author: Hesketh, Paul
linked information resource: Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer.

Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer.
PubMed Identifier: 40256355
author list: Aglan M, Spyropoulous E, Oster J, Hesketh PJ, Piper-Vallillo AJ
published in: Respiratory medicine case reports
information resource reference: Aglan M, Spyropoulous E, Oster J, Hesketh PJ, Piper-Vallillo AJ. Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer. Respir Med Case Rep. 2025; 55:102200.
journal title abbreviation: Respir Med Case Rep
publication date: 2025-04-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjunct Professor
is primary position: true
position in department: Population and Quantitative Health Sciences
position in division: Health Informatics And Implementation Science
sort order: 1
type: Position
HR job title: Adjunct Professor
position in organization: UMass Chan Medical School

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Shin, Dong-Soo
first name: Dong-Soo
last name: Shin
full name: Dong-Soo Shin PhD, RN
has faculty rank: ADJUNCT PROFESSOR
Person ID: 10248397
person in primary position: Adjunct Professor
type: Agent
type: Person
preferred title: Adjunct Professor

Lamb, Carla
first name: Carla
last name: Lamb
full name: Carla Lamb MD
has faculty rank: Assistant Professor
Person ID: 10248401
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Chair and Professor
is primary position: true
position in department: Radiology at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Chair and Professor
position in organization: UMass Chan Medical School

Associate Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Associate Professor
position in organization: UMass Chan Medical School